Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexlansoprazole vs Rabeprazole Triple Therapy for H. pylori
NCT02541786Phase 4Completed
- Sponsor
- Kaohsiung Medical University
- Start
- Jan 2015
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexlansoprazole in Helicobacter pylori infection (2 arms), sponsored by Kaohsiung Medical University. Primary endpoint: The rate of H.pylori eradication. Started Jan 2015; status: completed.
02
Drugs
dexlansoprazole
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT02541786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02541786.